The THRA gene helps many tissues respond to thyroid hormone, which supports growth, brain development, body temperature, bowel activity, and heart function. If a harmful variant disrupts this signal, the body may act as though thyroid hormone is too low even when blood tests are close to normal. This gene plays an important role in how your body uses thyroid hormone day to day, and some people with variants in the THRA gene have constipation, short stature, delayed development, or tiredness.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can visit the LearnHub.
Overview
THRAGene function
What if the gene works
Your cells use the THRA gene to make a receptor for thyroid hormone. This helps tissues, especially the brain, heart, bones, and muscles, respond to thyroid signals that support growth, energy use, and development.
Risk
What if the gene does not work
Variants in the THRA gene can cause resistance to thyroid hormone α, often with constipation, short stature, delayed bone growth, and learning or movement differences. Milder or more severe variants can affect when symptoms appear and how marked they are.
Treatment
What does that mean for your treatment
Pathogenic variants in the THRA gene can change how parts of the body respond to thyroid hormone. Management often uses thyroid hormone replacement, usually levothyroxine and sometimes liothyronine, with careful adjustment based on symptoms, growth, and heart rate, not just routine blood tests. Response varies by variant and age.
Conditions associated with THRA
Gene function
What if the gene works
Your body uses the THRA gene to read thyroid hormone signals in many tissues. Its protein acts like a switch that helps cells adjust which genes are active, especially in places such as the brain, heart, bones, and muscles. Understanding how the THRA gene works in the body helps explain how cells keep growth, energy use, and timing in balance.
The THRA gene makes a receptor, a protein that receives thyroid hormone signals inside cells. This allows cells to tell when thyroid hormone is present and respond in a measured way.
After sensing thyroid hormone, the THRA protein attaches near specific genes and adjusts how active they are. It works like a dimmer switch, helping cells turn sets of genes up or down as needed.
Many cells in the brain, heart, bones, muscles, and gut use THRA to follow thyroid hormone signals. This supports routine body functions such as growth, energy use, movement, and normal organ timing.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the THRA gene can alter the thyroid hormone receptor’s shape, making it less able to bind hormone, attach to DNA, or recruit partner proteins that control gene activity. In many people, this pattern underlies THRA gene variants and thyroid hormone resistance. Milder variants may partly reduce receptor activity, while more severe variants can strongly block signaling from the changed receptor and often relate to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the THRA gene cause resistance to thyroid hormone alpha, a genetic condition linked to constipation, short stature, delayed bone development, and learning or movement differences. Some people also have slow growth, anemia, or a slower heart rate. This THRA gene variant and thyroid hormone resistance link is well established, and a pathogenic THRA variant can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For THRA, risk is mainly set by whether a disease-causing variant is inherited or happens for the first time in a family. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of developing a THRA-related condition. Family history is the main factor that can raise risk for relatives.
Inheritance of THRA variants
THRA-related conditions are usually inherited in an autosomal dominant pattern, which means a person needs one disease-causing variant in the THRA gene to have the condition. If a parent carries the variant, each child has a 50% chance of inheriting it. Some people diagnosed with a THRA-related condition have a new (de novo) variant, meaning it was not inherited from either parent. This is the main answer to how variants of the THRA gene are inherited.
What does my THRA result mean for my family?
For THRA, the best-known related condition is usually passed down in a dominant way, so a parent, brother, sister, or child may also carry the same gene change. That means close relatives may want to learn whether the variant is present, especially if they have symptoms such as tiredness, constipation, slow growth, or learning difficulties. Some THRA changes happen for the first time in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a THRA variant, doctors use THRA genetic testing for thyroid hormone resistance alpha on DNA from a blood or saliva sample. A lab reads the THRA gene and checks for variants that may explain symptoms. Results can identify a causative variant, find no relevant change, or show a variant that needs more interpretation.
When should I consider getting a genetic test?
Consider THRA genetic testing when there are signs of resistance to thyroid hormone alpha, such as long-term constipation, slow growth, developmental delay, unusual tiredness, or thyroid blood test results that do not match the symptoms. Testing can also help if these features run in the family.
A genetic result is only one part of your health story
How informative a genetic result is depends on the condition and on the type of variant involved. A result can provide meaningful insight, but many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, causes more side effects in another, or seems to have less effect in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines the way inherited genetic differences affect a person’s response to medicines. It studies links between genes and medications to explain why the same treatment may work differently in different people. For many drugs, genes can influence both how much effect a medicine has and how the body handles it. This information can support treatment choices that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the THRA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. If you have concerns about side effects, an unexpected response to treatment, or your overall health, talk with your doctor or pharmacist.
History
The THRA gene entered medical research in the 1980s, during a period when scientists were identifying many hormone receptor genes for the first time. It first drew attention because it was closely related to an older cancer research finding called c-erbA, which helped researchers realize it belonged to an important family of genes. Building on this early work, scientists uncovered more about the THRA gene and separated it from the related thyroid hormone receptor beta pathway. A major clinical milestone came much later, when inherited THRA variants were linked to resistance to thyroid hormone alpha, giving a clear explanation for a pattern of growth, bowel, and thyroid related features seen in some families. That discovery helped turn THRA from a research gene into one with direct clinical relevance.